Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection
Open Access
- 15 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (6) , 973-983
- https://doi.org/10.1086/605447
Abstract
BackgroundActivation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their assKeywords
This publication has 30 references indexed in Scilit:
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV InfectionPLoS Medicine, 2008
- Serum amyloid A: An acute-phase protein involved in tumour pathogenesisCellular and Molecular Life Sciences, 2008
- Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical TrialsHIV Research & Clinical Practice, 2008
- Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-upThe Journal of Infectious Diseases, 2008
- C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor settingAIDS, 2007
- CD4+ Count–Guided Interruption of Antiretroviral TreatmentNew England Journal of Medicine, 2006
- C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease ProgressionArchives of internal medicine (1960), 2006
- Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patientsClinical and Experimental Immunology, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- The Role of the Tumor Necrosis Factor System and Interleukin‐10 during Cytomegalovirus Infection in Renal Transplant RecipientsThe Journal of Infectious Diseases, 2000